

In a groundbreaking collaboration, Professors Jang Hyun Choi and Sung Ho Park from UNIST’s Department of Biological Sciences have unveiled a critical element in the genesis of obesity-induced non-alcoholic fatty liver disease (NAFLD).
Their study highlights Thrap3, a protein linked to thyroid hormone receptors, as a key contributor to the worsening of NAFLD. Thrap3’s role is to suppress adenosine monophosphate-activated protein kinase (AMPK), a pivotal regulator of liver fat metabolism. These findings were published in the journal Experimental & Molecular Medicine.
NAFLD comprises a range of metabolic disorders, including fatty hepatitis and cirrhosis, arising from excessive fat buildup. Despite its widespread occurrence, viable NAFLD treatments have remained limited. However, this pioneering investigation unveils potential therapeutic avenues.
Utilizing rat-based experiments, the research group illustrated Thrap3’s direct binding to liver-based AMPK. This binding hinders AMPK’s migration from the nucleus to the cytoplasm, compromising the critical process of autophagy responsible for triglyceride breakdown and cholesterol reduction. Consequently, targeting Thrap3 expression emerges as a promising strategy for treating NAFLD effectively.
We have encountered significant challenges while developing treatment strategies for non-alcoholic fatty liver disease. However, our discovery of the Thrap3 gene provides us with an effective method to tackle this condition,” commented Professor Choi.
Furthermore, it was verified that the effective inhibition of Thrap3 expression leads to notable improvements in non-alcoholic steatohepatitis (NASH), an inflammatory condition linked to fatty liver.
An abstract from the Nature Journal reports – Autophagy is vital for cellular health and metabolism. Dysregulated autophagy contributes significantly to nonalcoholic fatty liver disease (NAFLD) progression. It aids lipid breakdown and maintains healthy mitochondria. However, the mechanisms behind autophagy disruption in NAFLD were unclear. Our study reveals increased Thrap3 expression in NAFLD, and liver-specific Thrap3 deletion improved lipid metabolism and autophagy in an NAFLD model. Thrap3 deficiency facilitated AMPK translocation and activation via direct interaction. This highlights Thrap3’s role in NAFLD and its potential as a treatment target.
more recommended stories
Ultra-Processed Foods May Harm Brain Health in Children
Ultra-Processed Foods Linked to Cognitive and.
Parkinson’s Disease Care Advances with Weekly Injectable
A new weekly injectable formulation of.
Brain’s Biological Age Emerges as Key Health Risk Indicator
Clinical Significance of Brain Age in.
Children’s Health in the United States is Declining!
Summary: A comprehensive analysis of U.S..
Autoimmune Disorders: ADA2 as a Therapeutic Target
Adenosine deaminase 2 (ADA2) has emerged.
Is Prediabetes Reversible through Exercise?
150 Minutes of Weekly Exercise May.
New Blood Cancer Model Unveils Drug Resistance
New Lab Model Reveals Gene Mutation.
Healthy Habits Slash Diverticulitis Risk in Half: Clinical Insights
Healthy Habits Slash Diverticulitis Risk in.
Caffeine and SIDS: A New Prevention Theory
For the first time in decades,.
Microbial Metabolites Reveal Health Insights
The human body is not just.
Leave a Comment